Wisconsin Pharmacal Company Revenue and Competitors
Estimated Revenue & Valuation
- Wisconsin Pharmacal Company's estimated annual revenue is currently $14.5M per year.
- Wisconsin Pharmacal Company's estimated revenue per employee is $225,900
Employee Data
- Wisconsin Pharmacal Company has 64 Employees.
- Wisconsin Pharmacal Company grew their employee count by 3% last year.
Wisconsin Pharmacal Company Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.5M | 4 | N/A | N/A | N/A |
#2 | $15.6M | 69 | 0% | N/A | N/A |
#3 | $0.9M | 7 | N/A | N/A | N/A |
#4 | $40M | 145 | N/A | N/A | N/A |
#5 | $471.2M | 1341 | 4% | N/A | N/A |
#6 | $20.1M | 80 | 0% | N/A | N/A |
#7 | N/A | 3371 | 4% | $677.5M | N/A |
#8 | $6.6M | 33 | -28% | N/A | N/A |
#9 | $75.4M | 273 | -7% | N/A | N/A |
#10 | $4M | 23 | 0% | N/A | N/A |
What Is Wisconsin Pharmacal Company?
Wisconsin Pharmacal Company is your source for Outdoor Health and Safety Solutions. Because you value the outdoors, we have dedicated our company to your recreational comfort and safety. Whether you're hunting, camping, hiking, biking, fishing, golfing or in the backyard, Wisconsin Pharmacal products are there to ease the way.
keywords:N/A
N/A
Total Funding
64
Number of Employees
$14.5M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Wisconsin Pharmacal Company News
The key and emerging market players in the Chlorine Dioxide Disinfectant market include SNiPER, Tristel, Wisconsin Pharmacal Company, ...
Global Chlorine Dioxide Disinfectant Market Insights Report 2019-2025: SNiPER, Tristel, Wisconsin Pharmacal Company, B & V Water ...
... (United States),Tristel (United Kingdom) ,Wisconsin Pharmacal Company (United States),B & V Water Treatment (United Kingdom) ,Scotmas ...
Other Companies in Jackson
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20.3M | 64 | 7% | N/A |
#2 | $18.7M | 64 | 12% | N/A |
#3 | $13.3M | 67 | -7% | N/A |
#4 | $12.4M | 67 | -11% | N/A |
#5 | N/A | 68 | 3% | N/A |
